Correction to: SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion
Crossref DOI link: https://doi.org/10.1186/s13063-022-06266-0
Published Online: 2022-04-21
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Halford, Sarah
Wan, Susan
Dragoni, Ilaria
Silvester, Julie
Nazarov, Bobojon
Anthony, Daniel
Anthony, Suzie
Ladds, Emma
Norrie, John
Dhaliwal, Kevin
,
Text and Data Mining valid from 2022-04-21
Version of Record valid from 2022-04-21
Article History
First Online: 21 April 2022